That’s your enervated opinion based upon your own personal view of one graph, and your opinion happens to run contrary to the leading Rett Syndrome researcher’s statement and commentary on the subject.
The same RS researcher who is our CMO and is in possession of all of the data regarding the trial and its participants and their open label extension data.